Gene Expression and Manipulation of Coxiella Burnetii

伯内氏柯克斯体的基因表达和操作

基本信息

  • 批准号:
    7641034
  • 负责人:
  • 金额:
    $ 70.15万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-05-01 至 2009-04-30
  • 项目状态:
    已结题

项目摘要

Introduction- Coxiella burnetii is the etiologic agent of Q fever, a potential bioweapon and select agent, and one of the most infectious pathogens known. However, there are few reports concerning this obligate intracellular agent's molecular pathogenesis or developmental cycle, and lack of a system for site-directed genetic manipulation has severely hampered research progress. To address this dearth of information and to improve the current state of molecular biology technology, we propose to: 1) examine the expression profiles of small cell variants (SCVs) and large cell variants (LCVs) of the developmental cycle to identify genes and proteins that allow Coxiella to survive for extended periods of time in the environment (SCV stage) and to subsequently grow in the inhospitable confines of the host cell phagolysosome (LCV stage); 2) analyze and compare expression profiles of in vitro versus in vivo-cultivated Coxiella and phase I versus phase II organisms to identify potential virulence determinants, and 3) develop a system of site-directed mutagenesis for this organism to allow for the routine genetic manipulation and future development of an attenuated vaccine strain. These data are expected to provide valuable information on the life cycle of Coxiella and the respective genes and proteins involved, and should lead to strategies for disrupting cellular development to control Q fever. Finally, a system for routine genetic manipulation of Coxiella is an essential molecular biology tool for examining suspected virulence genes and performing molecular Koch's postulates in vivo. Project Interactions- Project 3 (Harmsen) will interact with Project 1 (this study) as it relates to in vivocultivated Coxiella from the mouse model. Projects 4 (Pascual) and 2 (Jutila) will benefit from Project 1 data on stage-specific gene products; SCV-specific genes / antigens are hypothesized to be involved in transmission / early infection and LCV-specific genes / antigens are involved in intracellular replication.
伯氏柯克斯体是Q热的病原体,是潜在的生物武器和选择剂,以及 已知的最具传染性的病原体之一。然而,关于这一义务的报道却很少。 细胞内因子的分子发病机制或发育周期,以及缺乏定位的系统 基因操作严重阻碍了研究进展。为了解决这种信息匮乏的问题,并 针对分子生物学技术的现状,我们提出:1)检测基因表达谱 小细胞变异体(SCV)和大细胞变异体(LCV)的发育周期,以识别基因和 允许柯克斯体在环境中长时间存活的蛋白质(SCV阶段)和 随后在宿主细胞吞噬小体的不适宜居住的范围内生长(LCV阶段);2)分析和 比较体外和体内培养的柯克斯体和I期与II期的表达谱 生物体以确定潜在的毒力决定因素,以及3)开发一种定点突变系统 对于这种有机体来说,允许进行常规的基因操作和未来的减毒 疫苗株。这些数据有望提供有关柯克斯体生活史的宝贵信息 各自涉及的基因和蛋白质,并应导致干扰细胞发育的策略 控制Q热。最后,柯克斯体的常规遗传操作系统是必不可少的分子 用于检查疑似毒力基因并在体内执行分子科赫假设的生物学工具。 项目互动-项目3(Harmsen)将与项目1(本研究)互动,因为它与活动相关 小鼠模型中的柯克斯氏菌。项目4(Pascual)和项目2(Jutila)将受益于项目1的数据 在阶段特定的基因产物上;假设SCV特定的基因/抗原参与 传播/早期感染和LCV特异性基因/抗原参与了细胞内复制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Michael F Minnick其他文献

Michael F Minnick的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Michael F Minnick', 18)}}的其他基金

Targetomes of infection-specific small RNAs of Bartonella bacilliformis
杆状巴尔通体感染特异性小RNA的靶标组
  • 批准号:
    10414729
  • 财政年份:
    2022
  • 资助金额:
    $ 70.15万
  • 项目类别:
Targetomes of infection-specific small RNAs of Bartonella bacilliformis
杆状巴尔通体感染特异性小RNA的靶标组
  • 批准号:
    10606530
  • 财政年份:
    2022
  • 资助金额:
    $ 70.15万
  • 项目类别:
Small RNAs of Bartonella bacilliformis; the agent of Carrion's disease in humans
杆状巴尔通体的小RNA;
  • 批准号:
    9227738
  • 财政年份:
    2016
  • 资助金额:
    $ 70.15万
  • 项目类别:
Caenorhabditis elegans infection model for Coxiella burnetii
伯内氏柯克斯体的秀丽隐杆线虫感染模型
  • 批准号:
    9221965
  • 财政年份:
    2016
  • 资助金额:
    $ 70.15万
  • 项目类别:
Role of surface proteins in sand fly colonization by Bartonella bacilliformis
表面蛋白在杆状巴尔通体定植白蛉中的作用
  • 批准号:
    8303852
  • 财政年份:
    2012
  • 资助金额:
    $ 70.15万
  • 项目类别:
Role of surface proteins in sand fly colonization by Bartonella bacilliformis
表面蛋白在杆状巴尔通体定植白蛉中的作用
  • 批准号:
    8515923
  • 财政年份:
    2012
  • 资助金额:
    $ 70.15万
  • 项目类别:
Role of Coxiella burnetii group I introns in growth modulation
伯氏柯克斯体 I 组内含子在生长调节中的作用
  • 批准号:
    7587901
  • 财政年份:
    2009
  • 资助金额:
    $ 70.15万
  • 项目类别:
Role of Coxiella burnetii group I introns in growth modulation
伯氏柯克斯体 I 组内含子在生长调节中的作用
  • 批准号:
    7843521
  • 财政年份:
    2009
  • 资助金额:
    $ 70.15万
  • 项目类别:
Coxiella Cultivation Core
柯克斯体培养核心
  • 批准号:
    7641042
  • 财政年份:
    2008
  • 资助金额:
    $ 70.15万
  • 项目类别:
HEMIN RECEPTOR GENE FAMILY OF BARTONELLA QUINTANA
金塔纳巴尔通体的血红素受体基因家族
  • 批准号:
    7715619
  • 财政年份:
    2008
  • 资助金额:
    $ 70.15万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 70.15万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 70.15万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 70.15万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 70.15万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 70.15万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 70.15万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 70.15万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 70.15万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 70.15万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 70.15万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了